CAS Number677338-12-4
SynonymsS1187_Selleck; PIK-90; N-(7,8-Dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)nicotinamide; PIK90
Molecular FormulaC18H17N5O3
Molecular Weight351.36
Purity98.00%
Density1.2±0.1 g/cm3
Boiling Point817.3±65.0 °C at 760 mmHg
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 677338-12-4 |
| Catalog No. | 2A-9057886 |
| Chinese Name | 2-[(4-羟基苯基)甲基]-6-(4-羟基苯基)-8-(环戊基甲基)-咪唑并[1,2-a]吡嗪-3-(7H)-酮 |
| Synonyms | S1187_Selleck; PIK-90; N-(7,8-Dimethoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)nicotinamide; N-(2,3-Dihydro-7,8-dimethoxyimidazo[1,2-c]quinazolin-5-yl)nicotinamide; PIK90 |
| Molecular Formula | C18H17N5O3 |
| Molecular Weight | 351.36 |
| Purity | 98.00 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 817.3±65.0 °C at 760 mmHg |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | PIK-90 is a PI3K and DNA-PK inhibitor that inhibits p110α, p110γ, and DNA-PK with IC50 of 11, 18, and 13 nM, respectively. |
| MDL Number | C18H17N5O3 |
| MSDS | msds/57886_1_677338_12_4.pdf |
| Transport Info | Product name: PIK-90 |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 1-(3-Bromophenyl)-1-methylethylamine hydrochloride | 676135-18-5 | 2A-9057868 |
| 3-tert-Butyl-6-[(2-ethylhexyl)thio]aniline | 676352-86-6 | 2A-9057871 |
| Methyl 3-cyano-4-fluorobenzoate | 676602-31-6 | 2A-9057877 |
| Motavizumab | 677010-34-3 | 2A-9057878 |
| 1,4,7,10-Tetra(tert-butyl)perylene | 677275-33-1 | 2A-9057879 |
| 9,9-Dimethyl-N,N'-bis(3-methylphenyl)-N,N'-diphenyl-9H-fluorene-2,7-diamine | 677350-83-3 | 2A-9057887 |
| N-[4-[(Aminoiminomethyl)amino]phenyl]methanesulfonamide | 677752-76-0 | 2A-9057889 |
| 3-Amino-4-(3-methylphenyl)butyric acid | 678969-19-2 | 2A-9057891 |
| 3-Amino-4-(4-chlorophenyl)butyric acid | 678969-20-5 | 2A-9057892 |
| 1-(3-Hydroxyphenyl)-2-(methylamino)ethanone sulfate | 679394-62-8 | 2A-9057894 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS